Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myla Lai-Goldman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Personalized Medicine|May 23, 2018
HLA-B*5701 screening for hypersensitivity to abacavirHawazin Faruki, Myla Lai-Goldman
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 19, 2008
Abacavir hypersensitivity: a model system for pharmacogenetic test adoptionMyla Lai-Goldman, Hawazin Faruki
Personalized Medicine|May 24, 2018
Application of a pharmacogenetic test adoption model to six oncology biomarkersHawazin Faruki, Myla Lai-Goldman
Pharmacogenetics and Genomics|September 22, 2007
HLA-B*5701 clinical testing: early experience in the United StatesHawazin Faruki, Uwe Heine, Trisha Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2017
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune LandscapeHawazin Faruki, Gregory M Mayhew, Jonathan S Serody, et al.
Clinical Colorectal Cancer|March 4, 2006
Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal testsBarry M Berger, Paul C Schroy, Jennifer L Rosenberg, et al.
Archives of Pathology & Laboratory Medicine|October 3, 2015
Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data SetsHawazin Faruki, Gregory M Mayhew, Cheng Fan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Personalized Medicine|May 23, 2018
HLA-B*5701 screening for hypersensitivity to abacavirHawazin Faruki, Myla Lai-Goldman
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 19, 2008
Abacavir hypersensitivity: a model system for pharmacogenetic test adoptionMyla Lai-Goldman, Hawazin Faruki
Personalized Medicine|May 24, 2018
Application of a pharmacogenetic test adoption model to six oncology biomarkersHawazin Faruki, Myla Lai-Goldman
Pharmacogenetics and Genomics|September 22, 2007
HLA-B*5701 clinical testing: early experience in the United StatesHawazin Faruki, Uwe Heine, Trisha Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2017
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune LandscapeHawazin Faruki, Gregory M Mayhew, Jonathan S Serody, et al.
Clinical Colorectal Cancer|March 4, 2006
Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal testsBarry M Berger, Paul C Schroy, Jennifer L Rosenberg, et al.
Archives of Pathology & Laboratory Medicine|October 3, 2015
Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data SetsHawazin Faruki, Gregory M Mayhew, Cheng Fan, et al.
Pageof 1